Identity
- Security key
- 13683
- Ticker
- COYA
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2022-12-29
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- COYA
Detail
Enriched 2026-08-14 20:47
- Market cap
- $110,017,311.81
- Shares outstanding (class)
- 23,457,183
- Shares outstanding (weighted)
- 23,457,849
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 8
- Location
- HOUSTON, TX
- Homepage
- https://www.coyatherapeutics.com
- Description
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.